Barrow Neurological Foundation

• NCT02469896

  Collaborator, Phase 2, Completed, 22 people, 12 Jun 2015

• Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease risk

  27 Aug 2026

• Intracranial aneurysms as a manifestation of premature vascular aging: Cellular senescence, inflammaging, and wall degeneration

  27 Aug 2026

• Timing of cognitive decline onset and life-course trajectories A pooled longitudinal analysis of 14,389 adults across three cohorts

  7 Aug 2026

• Lifestyle strategies and mechanistic implications for slowing neurodegeneration

  2 Mar 2026

• Dietary Patterns Influence Chronic Disease Risk and Health Outcomes in Older Adults: A Narrative Review

  13 Dec 2025

• The longitudinal association between dyslipidemia and cognitive trajectory

  23 Oct 2025

• Intra-Arterial Deoxyribonuclease Therapy Improves Stroke Outcomes in Aged Mice

  #3033227, 1 Jun 2025

Sources: api.crossref.org

• Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders

  Grants or research support, 19 Dec 2025

• The longitudinal association between dyslipidemia and cognitive trajectory

  Grants or research support, 23 Oct 2025

• Depression and Cognitive Outcomes: Linking the Mayo Clinic Study of Aging and Rochester Epidemiology Project

  Grants or research support, 26 Aug 2025

Sources: pubmed.ncbi.nlm.nih.gov

• Timing of cognitive decline onset and life-course trajectories A pooled longitudinal analysis of 14,389 adults across three cohorts

  The journal of prevention of Alzheimer's disease, 7 Aug 2026